Avantor, Inc. (NYSE:AVTR) Shares Bought by Amalgamated Bank

Amalgamated Bank boosted its position in shares of Avantor, Inc. (NYSE:AVTR) by 771.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 323,970 shares of the company’s stock after buying an additional 286,811 shares during the quarter. Amalgamated Bank’s holdings in Avantor were worth $8,381,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Intech Investment Management LLC lifted its holdings in Avantor by 1.8% during the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock valued at $616,000 after purchasing an additional 514 shares in the last quarter. Arizona State Retirement System lifted its stake in Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock valued at $3,955,000 after buying an additional 528 shares in the last quarter. Veracity Capital LLC boosted its holdings in Avantor by 1.0% in the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after buying an additional 543 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Avantor by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after buying an additional 733 shares in the last quarter. Finally, US Bancorp DE raised its holdings in shares of Avantor by 6.2% during the third quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after acquiring an additional 734 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by insiders.

Avantor Price Performance

NYSE:AVTR opened at $22.97 on Thursday. The company has a market capitalization of $15.63 billion, a P/E ratio of 49.93, a P/E/G ratio of 2.70 and a beta of 1.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 52 week low of $18.08 and a 52 week high of $28.00. The stock’s fifty day moving average is $25.03 and its two-hundred day moving average is $24.14.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AVTR shares. Stifel Nicolaus lifted their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Barclays lowered their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Finally, UBS Group cut their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and an average price target of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.